Anganwadi workers to protest on Sep 22

DHNS
September 19, 2017

Bengaluru, Sept 19: Anganawadi workers will hold demonstrations in front of the deputy commissioners’ offices in all districts in the state on September 22, against increased work pressure on them because of the Mathrpoorna scheme.

B Nagarathnamma , secretary of Karnataka State Anganwadi Workers’ Association, said it is difficult for them to reach the true beneficiaries of the scheme. The scheme provides for supply of food to pregnant and lactating women.

Comments

George
 - 
Tuesday, 19 Sep 2017

Either govt should recruit more teachers/leave the scheme or hike their salary

Ganesh
 - 
Tuesday, 19 Sep 2017

My aunty working as anganavadi teacher. personally i know how difficult it is

Danish
 - 
Tuesday, 19 Sep 2017

People may think in rural area, anganavady worker are less educated and anyone can work. but they are doing great job. should leave the scheme which gives extra work

Hari
 - 
Tuesday, 19 Sep 2017

Govt should consider them as human beings. They are working like anything and they get paid very less

Kumar
 - 
Tuesday, 19 Sep 2017

They deserve more salary. 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 15,2020

Mangaluru, Feb 15: Dense fog formation and poor visibility at the runway forced to delay and diversions of some flights arriving and take off at the Mangaluru International Airport (MIA) on Saturday.

Flights take off and landings were suspended from 0700 hours am to 1030 hours.

Many flights to land in the morning were diverted.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 26,2020

Bengaluru, Jun 26: A 60-year-old woman, who tested positive for COVID-19 positive and was undergoing treatment, allegedly committed suicide by hanging herself in the restroom of KC General hospital last night.

According to the police, the 60-year-old female COVID-19 patient hung herself in the restroom of KC general hospital in Bengaluru. She was admitted to the hospital on June 18 along with her daughter-in-law and grandson.

"Around 2 am, she went to the washroom. When she did not return back, her daughter-in-law went to check where she found her hanging dead," confirmed Bengaluru police.

An investigation into the matter is underway, police said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.